Hydrogen Research Study
← Back to Research Library
Laboratory or cellular evidenceLaboratory StudyOther or not reported

A green, efficient and precise hydrogen therapy of cancer based on in vivo electrochemistry.

Guohua Qi, Bo Wang, Xiangfu Song, Haijuan Li, Yongdong Jin · National science review · 2020

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Cancer and Supportive Oncology Research
Evidence type Laboratory or cellular evidence
Publication type Laboratory Study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In a laboratory model, when the tumor size reached ∼200 mm 3, each tumor-bearing mouse was treated for 10 min a time twice a day for 3 days using H₂ -ECT and then observed for 12 days, as shown in Fig. The authors concluded that due to the disadvantages of insufficient and uncontrollable release of H₂ along with potential metabolic toxicity, current attempts to use nanomaterials as H₂ carriers are still far from clinical oncotherapy. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. When the tumor size reached ∼200 mm 3, each tumor-bearing mouse was treated for 10 min a time twice a day for 3 days using H₂ -ECT and then observed for 12 days, as shown in Fig.

What the Researchers Studied

The study used a in vitro cell-culture laboratory experiment.

What Effects Did Molecular Hydrogen Have?

When the tumor size reached ∼200 mm 3, each tumor-bearing mouse was treated for 10 min a time twice a day for 3 days using H₂ -ECT and then observed for 12 days, as shown in Fig. The authors concluded that due to the disadvantages of insufficient and uncontrollable release of H₂ along with potential metabolic toxicity, current attempts to use nanomaterials as H₂ carriers are still far from clinical oncotherapy.

Why These Findings Matter

These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.

How Strong Is This Evidence?

This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.

Technical Study Details

H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The study used a in vitro cell-culture laboratory experiment.

Limitations and Safety

Reported limitations: The reason is that limited tumor local electrolytes near the electrodes will be depleted during one rushing EC run due to the diffusion limitation.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.